PL2525782T3 - Preparaty nanonośników i sposoby ich wytwarzania - Google Patents

Preparaty nanonośników i sposoby ich wytwarzania

Info

Publication number
PL2525782T3
PL2525782T3 PL11732743T PL11732743T PL2525782T3 PL 2525782 T3 PL2525782 T3 PL 2525782T3 PL 11732743 T PL11732743 T PL 11732743T PL 11732743 T PL11732743 T PL 11732743T PL 2525782 T3 PL2525782 T3 PL 2525782T3
Authority
PL
Poland
Prior art keywords
nano
formulations
carriers
preparing
methods
Prior art date
Application number
PL11732743T
Other languages
English (en)
Inventor
Manish Doshi
Divyesh Sherdiwala
Prakash Sojitra
Original Assignee
Concept Medical Research Private Limited
Envision Scientific Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concept Medical Research Private Limited, Envision Scientific Private Limited filed Critical Concept Medical Research Private Limited
Publication of PL2525782T3 publication Critical patent/PL2525782T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624—Nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL11732743T 2010-01-18 2011-01-06 Preparaty nanonośników i sposoby ich wytwarzania PL2525782T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN133MU2010 2010-01-18
EP11732743.7A EP2525782B1 (en) 2010-01-18 2011-01-06 Formulations of nano-carriers and methods of preparing the same
PCT/IN2011/000006 WO2011086574A2 (en) 2010-01-18 2011-01-06 Formulations of nano-carriers and methods of preparing the same

Publications (1)

Publication Number Publication Date
PL2525782T3 true PL2525782T3 (pl) 2019-09-30

Family

ID=44304741

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11732743T PL2525782T3 (pl) 2010-01-18 2011-01-06 Preparaty nanonośników i sposoby ich wytwarzania

Country Status (9)

Country Link
US (1) US20120321670A1 (pl)
EP (1) EP2525782B1 (pl)
CA (1) CA2786671A1 (pl)
DK (1) DK2525782T3 (pl)
ES (1) ES2726952T3 (pl)
PL (1) PL2525782T3 (pl)
PT (1) PT2525782T (pl)
TR (1) TR201906372T4 (pl)
WO (1) WO2011086574A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2926797A1 (en) 2013-10-14 2015-04-23 Nanosphere Health Sciences, Llc Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
CA2961746A1 (en) * 2014-09-17 2016-03-24 Vivacelle Bio, Inc. Stable micelle and/or liposome compositions and uses thereof
US11707436B2 (en) 2014-12-15 2023-07-25 Nanosphere Health Sciences Inc. Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of NSAIDS
CN104586817A (zh) * 2015-02-11 2015-05-06 苏州大学 一种多西他赛固体脂质纳米粒冻干制剂及其制备方法
CA3089686A1 (en) 2015-03-10 2016-09-15 Nanosphere Health Sciences, Llc A nanoparticle drug delivery comprising liquid lipids and cannabinoids encapsulated in a single layer of essential phospholipids
CA3119037A1 (en) 2018-12-11 2020-06-18 Disruption Labs Inc. Compositions for the delivery of therapeutic agents and methods of use and making thereof
CN119431400A (zh) 2020-03-27 2025-02-14 波士顿科学国际有限公司 用于使药物结晶的方法
CN111671982A (zh) * 2020-05-08 2020-09-18 北京永益润成科技有限公司 一种药物涂层组合物及其制备方法
US20240108732A1 (en) * 2022-03-10 2024-04-04 Nammi Therapeutics, Inc. Formulated and/or Co-Formulated Lipid Nanocarriers Compositions Containing Toll-Like Receptor ("TLR") Agonist Prodrugs Useful In The Treatment of Cancer and Methods Thereof
CN114886855B (zh) * 2022-05-19 2023-10-03 北京柏欧利诺生物科技有限公司 一种雷公藤红素纳米药物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040208877A1 (en) * 2002-07-01 2004-10-21 Avigdor Levanon Antibodies and uses thereof
US7179484B2 (en) * 2002-11-06 2007-02-20 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
JP4684991B2 (ja) * 2003-01-31 2011-05-18 ボストン サイエンティフィック リミテッド 薬物添加ナノカプセルを用いる局所的薬物デリバリー
CN1493361A (zh) * 2003-08-29 2004-05-05 上海医药工业研究院 山榆酸甘油酯的脂质纳米粒及其制备方法
AU2005219413A1 (en) * 2004-03-02 2005-09-15 Massachusetts Institute Of Technology Nanocell drug delivery system
BRPI0600275A (pt) * 2006-01-03 2007-10-02 Brz Biotecnologia Ltda prótese coronária liberadora de composição medicamentosa para prevenção e tratamento da reestenose e processo de fabricação
US20090110739A1 (en) * 2007-05-15 2009-04-30 University Of North Texas Health Science Center At Forth Worth Targeted cancer chemotherapy using synthetic nanoparticles
DE102007061624A1 (de) * 2007-05-31 2009-06-25 Ernst-Moritz-Arndt-Universität Greifswald Verfahren zur Beschichtung von Oberflächen mit Mikro- und Nanopartikeln mit Hilfe von Plasmaverfahren und dessen Verwendung
CN101167699A (zh) * 2007-11-28 2008-04-30 厦门大学 胰岛素口服缓释制剂及其制备方法
US8343497B2 (en) * 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
JP5861632B2 (ja) * 2009-05-29 2016-02-16 エンヴィジョン サイエンティフィック プライベート リミテッド ナノカプセル化薬物をそのために設計された医療装置を通して送り、身体のｐＨを用いてヒト動脈内でナノカプセル化薬物を放出させることによる遮断されたヒト動脈における血流再開
RU2573045C2 (ru) * 2009-06-02 2016-01-20 Консепт Медикал Инк. Медицинское устройство, доставляющее лекарственное средство, способ его получения и способ доставки лекарственного средства

Also Published As

Publication number Publication date
US20120321670A1 (en) 2012-12-20
EP2525782A2 (en) 2012-11-28
ES2726952T3 (es) 2019-10-10
PT2525782T (pt) 2019-06-06
CA2786671A1 (en) 2011-07-21
WO2011086574A3 (en) 2011-11-10
TR201906372T4 (tr) 2019-05-21
WO2011086574A2 (en) 2011-07-21
DK2525782T3 (da) 2019-06-11
EP2525782B1 (en) 2019-03-13
EP2525782A4 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
GB2507210B (en) Insecticidal compositions and methods of using the same
EP2568954A4 (en) FRAGRANCE FORMULATIONS, METHOD FOR THE PRODUCTION THEREOF AND ARTICLES THEREWITH
PT2525782T (pt) Formulações de nanoveículos e métodos de preparação dos mesmos
IL223215A0 (en) Nanowire catalsyts and methods of producing the same
ZA201300193B (en) Formulations of rifaximin and uses thereof
ZA201300002B (en) Novel processes for the preparation of phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
IL222969A0 (en) Sweetener compositions and methods of preparing the same
EP2563372A4 (en) PREBIOTIC FORMULATIONS AND METHODS OF USE
ZA201300930B (en) St-246 liquid formulations and methods
PL2605757T3 (pl) Preparaty oparte na nalbufinie i ich zastosowania
PT2521445T (pt) Formulação e utilização da mesma
ZA201208229B (en) Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
EP2571946A4 (en) STRIPPING COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
EP2525651A4 (en) NEW CENTROMERE AND METHOD FOR THEIR USE
PL2544548T3 (pl) Sposób wytwarzania stabilnego i jednorodnego preparatu owocowego
SG10201604468QA (en) Shk-based pharmaceutical compositions and methods of manufacturing and using the same
ZA201404826B (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
IL226174A0 (en) Impulse preparations and methods for their preparation
EP2649217A4 (en) ARTICLE AND METHOD FOR ITS MANUFACTURE AND USE
EP2536407A4 (en) TAXAN-PRO-EMULSION FORMULATIONS AND METHOD FOR THEIR MANUFACTURE AND USE
GB201020357D0 (en) Compounds and methods of making the same
IL226234B (en) Nucleons, ribocapsids and methods for their production
PL391702A1 (pl) Sposób otrzymywania 5-hydroksykreatyniny i N-metyloguanidyny
GB201003741D0 (en) Methods and therapeutic compositions